Sign in
AZTR Stock Price, Chart, Stats & News
Azitra, Inc.
Save
Azitra, Inc. (AZTR) does not currently pay a dividend.
–
Market cap
–
Current P/E
–
Forward P/E
AZTR chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | -0.08% |
ROA | -218.00% |
ROE | -344.59% |
D/E | 0.16x |
Interest coverage ratio | -14.82x |
AZTR valuation
P/E | – |
P/S | – |
P/B | 0.31x |
P/CF | -0.01x |
P/FCF | -0.03x |
P/OCF | -0.01x |
PEG | 0.01x |
EV multiple | -0.41x |
About
Azitra, Inc. is a pre-clinical biopharmaceutical company focused on developing precise treatments for various dermatological conditions. They innovate by utilizing engineered proteins and live biotherapeutic products to address skin diseases. The company's pipeline features several key therapeutic candidates: ATR-12: A genetically modified strain of S. epidermidis intended to treat Netherton syndrome, a specific skin disorder.
Similar securities
Based on sector and market capitalization
Report issue